ERBB2 and colonic neoplasm: Another study also showed that inhibiting Nrf2 signaling in colon cancer patients with Her2 overexpression was an important strategy to overcome oxaliplatin resistance, which further indicating Nrf2 was an important target for enhancing chemotherapy sensitivity36.